Viracta Therapeutics (VIRX)
NASDAQ:VIRX
Holding VIRX?
Track your performance easily

Viracta Therapeutics (VIRX) Financial Statements

837 Followers

Viracta Therapeutics Financial Overview

Viracta Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.236; its P/E ratio is -0.43; Viracta Therapeutics is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.28M$ -12.84M$ -11.65M$ -11.59M$ -12.12M
EBITDA$ -8.17M$ -11.13M$ -11.52M$ -12.01M$ -12.52M
Net Income Common Stockholders$ -9.14M$ -13.58M$ -12.60M$ -12.48M$ -12.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.57M$ 53.69M$ 62.95M$ 72.87M$ 80.33M
Total Assets$ 41.33M$ 56.69M$ 66.44M$ 76.86M$ 85.66M
Total Debt$ 18.86M$ 25.56M$ 25.56M$ 25.55M$ 25.54M
Net Debt$ -20.71M$ -28.14M$ -37.39M$ -47.31M$ -54.79M
Total Liabilities$ 30.25M$ 38.37M$ 36.43M$ 36.08M$ 34.67M
Stockholders Equity$ 11.08M$ 18.32M$ 30.01M$ 40.78M$ 51.11M
Cash Flow-
Free Cash Flow$ -7.85M$ -10.03M$ -10.48M$ -8.18M$ -11.34M
Operating Cash Flow$ -7.85M$ -10.03M$ -10.54M$ -7.99M$ -11.34M
Investing Cash Flow$ 14.19M$ 9.27M$ 9.10M$ 3.98M$ -7.35M
Financing Cash Flow$ -6.60M$ 218.00K-$ 204.00K$ 16.00K
Currency in USD

Viracta Therapeutics Earnings and Revenue History

Viracta Therapeutics Debt to Assets

Viracta Therapeutics Cash Flow

Viracta Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis